| Nome |
# |
|
Clinical implications of the hyperdynamic syndrome in cirrhosis., file e3ad8916-d293-da0e-e053-3705fe0a2b96
|
1.985
|
|
Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea, file e3ad8916-5915-da0e-e053-3705fe0a2b96
|
808
|
|
Il carcinoma del colon-retto: Un approccio basato sulle evidenze, file e3ad891a-617f-da0e-e053-3705fe0a2b96
|
538
|
|
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease, file e3ad891a-2ca1-da0e-e053-3705fe0a2b96
|
500
|
|
CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants, file e3ad8916-a442-da0e-e053-3705fe0a2b96
|
453
|
|
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C, file e3ad8916-ddea-da0e-e053-3705fe0a2b96
|
416
|
|
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease., file e3ad8916-cfd9-da0e-e053-3705fe0a2b96
|
370
|
|
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection., file e3ad8916-ddec-da0e-e053-3705fe0a2b96
|
352
|
|
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma., file e3ad8915-9dde-da0e-e053-3705fe0a2b96
|
328
|
|
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study, file e3ad891a-6eba-da0e-e053-3705fe0a2b96
|
327
|
|
Genetic predisposition to thrombophilia in inflammatory bowel disease, file e3ad8916-5be1-da0e-e053-3705fe0a2b96
|
297
|
|
When and how to treat acute hepatitis C?, file e3ad891a-8a77-da0e-e053-3705fe0a2b96
|
293
|
|
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C, file e3ad891b-033f-da0e-e053-3705fe0a2b96
|
292
|
|
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis, file e3ad891c-add2-da0e-e053-3705fe0a2b96
|
287
|
|
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease, file e3ad8916-ed8e-da0e-e053-3705fe0a2b96
|
284
|
|
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease., file e3ad891d-be37-da0e-e053-3705fe0a2b96
|
273
|
|
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting., file e3ad8917-0ebd-da0e-e053-3705fe0a2b96
|
248
|
|
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C., file e3ad8919-b138-da0e-e053-3705fe0a2b96
|
237
|
|
Treatment of hepatitis C: critical appraisal of the evidence, file e3ad891a-67aa-da0e-e053-3705fe0a2b96
|
216
|
|
Retreatment with pegylated interferon plus ribavirin of chronic
hepatitis C non-responders to interferon plus ribavirin: A meta-analysis., file e3ad891a-6d84-da0e-e053-3705fe0a2b96
|
216
|
|
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity, file e3ad891c-f2e5-da0e-e053-3705fe0a2b96
|
203
|
|
Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons, file e3ad8916-57fb-da0e-e053-3705fe0a2b96
|
202
|
|
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women, file e3ad8918-8dba-da0e-e053-3705fe0a2b96
|
201
|
|
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file e3ad8916-a2c9-da0e-e053-3705fe0a2b96
|
194
|
|
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study., file e3ad891c-d676-da0e-e053-3705fe0a2b96
|
194
|
|
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease, file e3ad8918-87d9-da0e-e053-3705fe0a2b96
|
178
|
|
Survival of Patients with Hepatocellular Carcinoma (HCC)
Treated by Percutaneous Radio-Frequency Ablation
(RFA) Is Affected by Complete Radiological Response, file e3ad8916-92d5-da0e-e053-3705fe0a2b96
|
163
|
|
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease, file e3ad8919-5179-da0e-e053-3705fe0a2b96
|
154
|
|
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites., file e3ad8917-0737-da0e-e053-3705fe0a2b96
|
153
|
|
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis, file e3ad8918-821d-da0e-e053-3705fe0a2b96
|
149
|
|
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis, file e3ad8918-a3bb-da0e-e053-3705fe0a2b96
|
147
|
|
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma, file e3ad8925-b798-da0e-e053-3705fe0a2b96
|
142
|
|
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis., file e3ad8916-a282-da0e-e053-3705fe0a2b96
|
141
|
|
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis, file e3ad8921-7aa4-da0e-e053-3705fe0a2b96
|
140
|
|
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis, file e3ad891a-3675-da0e-e053-3705fe0a2b96
|
138
|
|
Hyperferritinemia is a risk factor
for steatosis in chronic liver disease., file e3ad891a-6d82-da0e-e053-3705fe0a2b96
|
138
|
|
Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure, file e3ad8921-d557-da0e-e053-3705fe0a2b96
|
106
|
|
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use, file e3ad8924-dbbc-da0e-e053-3705fe0a2b96
|
91
|
|
Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway., file e3ad891a-3c1b-da0e-e053-3705fe0a2b96
|
89
|
|
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease, file e3ad8918-94a3-da0e-e053-3705fe0a2b96
|
88
|
|
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib, file e3ad8921-3982-da0e-e053-3705fe0a2b96
|
87
|
|
THE COMPLEX INTERPLAY BETWEEN VITAMIN D DEFICIENCY AND DIABETES, file e3ad8917-9532-da0e-e053-3705fe0a2b96
|
72
|
|
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE), file e3ad8926-eefc-da0e-e053-3705fe0a2b96
|
69
|
|
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data., file e3ad891a-5a20-da0e-e053-3705fe0a2b96
|
66
|
|
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease, file e3ad8920-83a3-da0e-e053-3705fe0a2b96
|
65
|
|
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib, file e3ad8923-e46f-da0e-e053-3705fe0a2b96
|
45
|
|
Hepatitis C in the elderly: a multicentre
cross-sectional study by the Italian Association for the Study of the Liver, file e3ad8916-57b7-da0e-e053-3705fe0a2b96
|
31
|
|
Outcomes of hepatocellular carcinoma patients treated with sorafenib: A meta-analysis of Phase III trials, file e3ad8927-abaf-da0e-e053-3705fe0a2b96
|
30
|
|
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease, file e3ad8928-65b7-da0e-e053-3705fe0a2b96
|
27
|
|
The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort, file 7d1e490b-9002-4755-b56e-3aee2a75452a
|
22
|
|
Prioritization of high-cost new drugs for HCV: making sustainability ethical, file e3ad8919-aaf5-da0e-e053-3705fe0a2b96
|
21
|
|
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints, file cd7a0e37-141f-45ab-9caa-19d414fdddfd
|
19
|
|
Young gastrointestinal angle: E-learning in gastroenterology: Future is now, file fdc28091-afcc-4835-be5f-0450e897eef4
|
19
|
|
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort, file e3ad8926-b3ad-da0e-e053-3705fe0a2b96
|
17
|
|
Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling, file 205d151c-82fc-44cc-9554-d73cea37165c
|
14
|
|
How important is the role of iterative liver direct surgery in patients with hepatocellular carcinoma for a transplant center located in an area with a low rate of deceased donation?, file 05af33b5-d2bb-4c5d-8442-7e899ea64e8d
|
12
|
|
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease, file e3ad8926-7f4c-da0e-e053-3705fe0a2b96
|
10
|
|
HCV: The best cure possible or the best possible cure?, file e3ad891c-b7fd-da0e-e053-3705fe0a2b96
|
8
|
|
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort, file e3ad891e-faad-da0e-e053-3705fe0a2b96
|
8
|
|
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis, file e3ad8927-e07b-da0e-e053-3705fe0a2b96
|
8
|
|
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease, file e3ad8928-6259-da0e-e053-3705fe0a2b96
|
8
|
|
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis, file b65f2698-031e-402b-a963-5240bbd08e95
|
7
|
|
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model, file e3ad8919-70a4-da0e-e053-3705fe0a2b96
|
7
|
|
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence, file e3ad8927-fe4a-da0e-e053-3705fe0a2b96
|
7
|
|
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease, file 13eb37ee-72fe-4bfe-8fd8-f24dee5a8a14
|
6
|
|
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study, file 28bec8b0-2af6-45a0-8ab7-3dbf18829309
|
6
|
|
Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection, file 4d91a867-c06b-4336-bc9b-f46028793d69
|
6
|
|
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors, file e3ad891c-be18-da0e-e053-3705fe0a2b96
|
6
|
|
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients, file e3ad8921-8e4f-da0e-e053-3705fe0a2b96
|
6
|
|
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis, file e3ad8923-d994-da0e-e053-3705fe0a2b96
|
6
|
|
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis, file e3ad8916-5a4f-da0e-e053-3705fe0a2b96
|
5
|
|
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values, file e3ad891b-8734-da0e-e053-3705fe0a2b96
|
5
|
|
The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases, file e3ad8922-86ba-da0e-e053-3705fe0a2b96
|
5
|
|
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis, file f387914d-6a4e-4659-ac64-86b3e41d5b59
|
5
|
|
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model, file dd42994e-737f-40ae-9c4b-ef8c000976fe
|
4
|
|
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies, file e3ad8918-7d4e-da0e-e053-3705fe0a2b96
|
4
|
|
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension, file e3ad8919-7e1f-da0e-e053-3705fe0a2b96
|
4
|
|
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease, file e3ad8919-ba3f-da0e-e053-3705fe0a2b96
|
4
|
|
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease, file e3ad8920-6e26-da0e-e053-3705fe0a2b96
|
4
|
|
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease, file e3ad8923-050f-da0e-e053-3705fe0a2b96
|
4
|
|
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals, file e3ad8927-20b0-da0e-e053-3705fe0a2b96
|
4
|
|
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival, file e3ad8928-0171-da0e-e053-3705fe0a2b96
|
4
|
|
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment, file e3ad8928-38c8-da0e-e053-3705fe0a2b96
|
4
|
|
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C., file e3ad8916-ed8d-da0e-e053-3705fe0a2b96
|
3
|
|
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing, file e3ad8919-57ed-da0e-e053-3705fe0a2b96
|
3
|
|
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents, file e3ad891d-5f52-da0e-e053-3705fe0a2b96
|
3
|
|
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. results from a prospective study, file e3ad8920-03b9-da0e-e053-3705fe0a2b96
|
3
|
|
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience, file e3ad8920-a956-da0e-e053-3705fe0a2b96
|
3
|
|
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis, file e3ad8926-f7dd-da0e-e053-3705fe0a2b96
|
3
|
|
Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting, file 2c7a4c0f-b207-4583-a698-a7b2a4779704
|
2
|
|
Reply, file 5ff3398d-0966-4de8-bc50-c3899293f413
|
2
|
|
Expert opinion vs. meta-analysis: To be or not to be?, file dd82a8d3-776b-437f-b21d-c8fa7391d129
|
2
|
|
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems, file e3ad8915-ece9-da0e-e053-3705fe0a2b96
|
2
|
|
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C., file e3ad8916-eaff-da0e-e053-3705fe0a2b96
|
2
|
|
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C, file e3ad8918-8db2-da0e-e053-3705fe0a2b96
|
2
|
|
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease, file e3ad891b-cb9b-da0e-e053-3705fe0a2b96
|
2
|
|
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma, file e3ad891b-d8df-da0e-e053-3705fe0a2b96
|
2
|
|
Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease, file e3ad891b-dbea-da0e-e053-3705fe0a2b96
|
2
|
|
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients, file e3ad891e-e05d-da0e-e053-3705fe0a2b96
|
2
|
|
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy, file e3ad8920-83a5-da0e-e053-3705fe0a2b96
|
2
|
| Totale |
12.542 |